Low testosterone treatments were slapped with another black-box warning—adding a general risk of blood clots in the veins to a growing list—FDA announced this past Friday. The agency already had required testosterone-product labeling to mention risk of ...

Low testosterone treatments were slapped with another black-box warning—adding a general risk of blood clots in the veins to a growing list—FDA announced this past Friday. The agency already had required testosterone-product labeling to mention risk of ...